2023-05-11T13:09:11-05:00 2022-12-31 HAN GROUP LLC 1020 19TH STREET NW SUITE 800 WASHINGTON DC 20036 990 2022-01-01 521609875 RESEARCHAMERICA RESE 7037392577 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 MICHAEL COBURN EVP & COO 7037392577 2023-05-09 1 MICHAEL COBURN 999009999 0 JENNIFER S HAN P00633304 2022937000 2023-05-09 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z MARY WOOLLEY 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 7906570 0 X WWW.RESEARCHAMERICA.ORG X 1989 DC ADVOCATES FOR SCIENCE, DISCOVERY AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL. 33 32 36 45 0 0 7916222 3958577 2327412 3584900 138177 -115627 -31107 20446 10350704 7448296 35345 37843 0 0 2883274 3736649 0 0 584137 1528825 2388356 4447444 6162848 5903260 1285448 11908481 13199606 2834131 3882297 9074350 9317309 X RESEARCH!AMERICA ADVOCATES FOR FUNDING FOR MEDICAL AND HEALTH RESEARCH FROM THE PUBLIC AND PRIVATE SECTORS AT A LEVEL WARRANTED BY SCIENTIFIC OPPORTUNITY AND SUPPORTED BY PUBLIC OPINION; RESEARCH!AMERICA ADVOCATES FOR POLICIES THAT SUPPORT MEDICAL PROGRESS AND INNOVATION ACROSS THE PUBLIC AND PRIVATE SECTORS. 0 0 2518015 1316800 ADVOCATING FOR SCIENCE, DISCOVERY, AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL:IN 2022, RESEARCH!AMERICA, ALONG WITH OUR MORE THAN 300 ALLIANCE MEMBER ORGANIZATIONS, WORKED TO ADVANCE FUNDING AND POLICY PRIORITIES AIMED AT SPEEDING MEDICAL PROGRESS, STRENGTHENING OUR NATION'S PUBLIC HEALTH SYSTEM, AND ASSURING OUR NATION SUSTAINS ITS VITAL STANDING AS THE GLOBAL LEADER IN SCIENCE AND INNOVATION. TO HELP KEEP MEMBERS INFORMED IN REAL TIME, RESEARCH!AMERICA HELD 46 ALLIANCE MEMBER MEETINGS FEATURING EXCEPTIONAL LEADERS FROM GOVERNMENT, ACADEMIA, AND INDUSTRY ON TIMELY TOPICS, SUCH AS MISINFORMATION AND DISINFORMATION, HUMAN GENOMICS AND PRECISION MEDICINE, GAIN OF FUNCTION RESEARCH, COMBATING HEALTH DISPARITIES AND FDA REGULATORY POLICY. RESEARCH!AMERICA ADVOCATED FOR INCREASED FEDERAL FUNDING FOR THE NATIONAL INSTITUTES OF HEALTH (NIH), CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), FOOD AND DRUG ADMINISTRATION (FDA), NATIONAL SCIENCE FOUNDATION (NSF), THE AGENCY FOR HEALTHCARE RESEARCH AND QUALITY (AHRQ) AND THE ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H). RESEARCH!AMERICA CONDUCTED 87 CONGRESSIONAL MEETINGS; PROVIDED CONGRESSIONAL TESTIMONY FOCUSED ON NIH, CDC, NSF, FDA, AND AHRQ; AND AUTHORED 74 LETTERS, INCLUDING SIGN-ON LETTERS TO CONGRESSIONAL LEADERSHIP. 947886 37843 SCIENCE OUTREACH AND CIVIC ENGAGEMENT: RESEARCH!AMERICA INCREASED ITS COMMITMENT TO SUPPORTING EARLY CAREER SCIENTISTS BY HOSTING ITS SECOND EARLY CAREER SUMMIT. RESEARCH!AMERICA ALSO OFFERED MICROGRANTS FOR GRADUATE-LEVEL SCIENCE POLICY AND CIVIC ENGAGEMENT INITIATIVES. AS IN PAST YEARS, THE PROGRAM IS HIGHLY COMPETITIVE WITH 20 GRANTS FUNDED OUT OF 68 APPLICATIONS FROM ACROSS THE COUNTRY. WE RELEASED A NEW REPORT, "THE RESEARCH!AMERICA MICROGRANT PROGRAM: EXPLORING ITS IMPACT ON EARLY CAREER SCIENTISTS," WHICH TAKES A DEEP DIVE INTO THE INITIATIVE. RESEARCH!AMERICA CONTINUES TO COORDINATE AND SUPPORT THE SCIENCE AND TECHNOLOGY ACTION COMMITTEE, AN INITIATIVE THAT HAS BROUGHT A DIVERSITY OF THOUGHT LEADERS TOGETHER TO MAKE THE CASE FOR A FAR BOLDER APPROACH TO BOLSTERING THE NATION'S R&D CAPACITY, INCLUDING SIGNIFICANTLY INCREASING THE PERCENTAGE OF THE GDP DEVOTED TO SCIENCE INVESTMENT. 763644 GLOBAL HEALTH R&D ADVOCACY: IN 2022, RESEARCH!AMERICA EXPANDED ITS GLOBAL HEALTH R&D ADVOCACY PROGRAM, COMPLETING THE FIRST YEAR OF A MULTI-YEAR GRANT PROJECT FUNDED BY THE BILL & MELINDA GATES FOUNDATION. THE GOAL OF THE PROJECT IS TO INCREASE UNITED STATES GOVERNMENT NON-OFFICIAL DEVELOPMENT ASSISTANCE (ODA) FUNDING FOR GLOBAL HEALTH RESEARCH & DEVELOPMENT, WITH PARTICULAR EMPHASIS ON ADVANCING INNOVATIVE CROSS-SECTOR PARTNERSHIPS AND OTHER EFFICIENCY-CREATING R&D STRATEGIES, INCLUDING PLATFORM TECHNOLOGIES AND GLOBAL CLINICAL TRIAL NETWORKS. 415500 1455500 ADVOCACY PROGRAMS: IN COLLABORATION WITH OUR MEMBERS WE HELD A NUMBER OF PROGRAMS TO HIGHLIGHT THE IMPACT OF MEDICAL RESEARCH AND INNOVATION. WE HOSTED A CONVENING OF LEADERS FROM ACADEMIA, NON-PROFITS, AND PHILANTHROPY TO DISCUSS HOW TO NORMALIZE BIDIRECTIONAL ENGAGEMENT WITH THE PUBLIC WITHIN THE CULTURE OF SCIENCE. ONE OF THE KEY TAKEAWAYS WAS THE NEED TO BETTER UNDERSTAND THE NATURE OF CIVIC SCIENCE TRAINING IN THE U.S. IN ORDER TO FILL GAPS AND CREATE ACTIONABLE BROADER SUPPORT. RESEARCH!AMERICA ALSO SERVED AS THE U.S. CONVENERS FOR A GLOBAL ECONOMIST IMPACT STUDY TO BETTER UNDERSTAND RESEARCHERS' OWN PERSPECTIVES OF THE STATE OF SCIENCE. MORE THAN HALF OF THE U.S. RESEARCHERS WHO RESPONDED WANT TRAINING TO BETTER COMMUNICATE WITH THE PUBLIC. WE CONTINUED TO ASSESS PUBLIC SENTIMENT ABOUT SCIENCE AND RESEARCH THROUGH THREE PUBLIC OPINION SURVEYS IN 2022: OUR MAJOR, ANNUAL OMNIBUS SURVEY IN JANUARY 2022; IN PARTNERSHIP WITH VIRGINIA TECH, WE SURVEYED VIRGINIANS' VIEWS ON THE ECONOMIC IMPACT OF BIOMEDICAL RESEARCH AND OPINIONS ON OTHER PUBLIC HEALTH AND SCIENCE ISSUES; WE COMMISSIONED A NATIONAL PUBLIC OPINION SURVEY ON BRAIN HEALTH AND BRAIN HEALTH RESEARCH. IN ADDITION TO OUR INDIVIDUAL SURVEYS, OUR AMERICA SPEAKS!: POLL DATA SUMMARY, VOLUME 22, DRAWS FROM THE PREVIOUS YEARS' SURVEYS AND SERVES AS A RESOURCE FOR ELECTED OFFICIALS. 215239 812600 NATIONAL HEALTH RESEARCH FORUM:RESEARCH!AMERICA HOSTED THE THREE-DAY NATIONAL HEALTH RESEARCH FORUM VIRTUALLY. THE FORUM EXPLORED HOW, TOGETHER, WE CAN DEFEAT THREATS THAT ROB US OF HEALTH, HOPE, AND TIME. THE FORUM ATTRACTED AN AUDIENCE OF MORE THAN 1,100 AND FEATURED 70 SPEAKERS, INCLUDING 13 HIGH-RANKING GOVERNMENT OFFICIALS. 630739 2268100 4860284 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 8 0 1 36 1 0 0 0 0 0 0 0 0 0 0 0 0 X 33 32 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR CA CO CT DC FL GA IL KS KY MA MD ME MI MS MN NC ND NJ NH NM NY OH OK OR PA RI SC TN UT VA WA WI WV X X MICHAEL COBURN 7037392577 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 MARY WOOLLEY PRESIDENT & CEO 50.00 X X 515368 0 67319 SUSAN DENTZER CHAIR 4.00 X X 0 0 0 HON MICHAEL N CASTLE CHAIR EMERITUS 4.00 X X 0 0 0 HON BART GORDON VICE CHAIR 4.00 X X 0 0 0 E ALBERT REECE MD PHD MBA SECRETARY 4.00 X X 0 0 0 AMY COMSTOCK RICK JD TREASURER 4.00 X X 0 0 0 TENLEY E ALBRIGHT MD DIRECTOR (UNTIL MARCH 2022) 1.00 X 0 0 0 GEORGES C BENJAMIN MD DIRECTOR 1.00 X 0 0 0 NANCY BROWN DIRECTOR 1.00 X 0 0 0 HON CHARLIE DENT DIRECTOR 1.00 X 0 0 0 MIKAEL DOLSTEN MD PHD DIRECTOR 1.00 X 0 0 0 VICTOR J DZAU MD DIRECTOR 1.00 X 0 0 0 KAFUI DZIRASA MD PHD DIRECTOR 1.00 X 0 0 0 AYMAN EL-MOHANDES MBBCH MD MPH FA DIRECTOR 1.00 X 0 0 0 ARTHUR C EVANS JR PHD DIRECTOR 1.00 X 0 0 0 DARIO GIL PHD DIRECTOR 1.00 X 0 0 0 WILLIAM N HAIT MD PHD DIRECTOR (UNTIL MARCH 2022) 1.00 X 0 0 0 MARY JC HENDRIX PHD DIRECTOR 1.00 X 0 0 0 HON RUSH D HOLT PHD DIRECTOR 1.00 X 0 0 0 JAMES L MADARA MD DIRECTOR (UNTIL MARCH 2022) 1.00 X 0 0 0 MARK MCCLELLAN MD PHD MPA DIRECTOR 1.00 X 0 0 0 MICHELLE MCMURRY-HEATH MD PHD DIRECTOR 1.00 X 0 0 0 JESSICA L MEGA MD MPH DIRECTOR 1.00 X 0 0 0 HERBERT PARDES MD DIRECTOR 1.00 X 0 0 0 SUDIP S PARIKH PHD DIRECTOR 1.00 X 0 0 0 HAROLD L PAZ MD MS DIRECTOR 1.00 X 0 0 0 MARY PITTMAN DRPH DIRECTOR 1.00 X 0 0 0 GUILLERMO J PRADO PHD DIRECTOR 1.00 X 0 0 0 DEREK K RAPP DIRECTOR 1.00 X 0 0 0 LAING ROGERS DIRECTOR 1.00 X 0 0 0 LEWIS G SANDY MD FACP DIRECTOR 1.00 X 0 0 0 HON DONNA SHALALA PHD DIRECTOR 1.00 X 0 0 0 LARRY J SHAPIRO MD DIRECTOR (UNTIL MARCH 2022) 1.00 X 0 0 0 DEBORAH TRAUTMAN PHD RN FAAN DIRECTOR 1.00 X 0 0 0 M ROY WILSON MD DIRECTOR 1.00 X 0 0 0 CYNTHIA ZAGIEBOYLO DIRECTOR 1.00 X 0 0 0 ELIAS ZERHOUNI MD DIRECTOR 1.00 X 0 0 0 MICHAEL COBURN EXECUTIVE VICE PRESIDENT & COO 45.00 X 288814 0 34795 ELEANOR DEHONEY VP - POLICY & ADVOCACY 45.00 X 256190 0 32555 JENNIFER LURAY VP - COMMUNICATONS 45.00 X 229747 0 44272 SHEILA H MURPHY VP - ADVOCACY PROGRAMS 45.00 X 198358 0 4383 ANNE MANDEVILLE VP - DEVELOPMENT 45.00 X 137102 0 1743 KATHERINE M GOODE SENIOR DIRECTOR - DEVELOPMENT 45.00 X 132233 0 13654 1757812 0 198721 9 0 1 0 SUBJECT MATTER - HOME FRONT COMMUNICATIO 1201 NEW YORK AVENUE NW 900 WASHINGTON DC 20005 ADVOCACY/ COMMUNICATIONS 477062 KEEFE SINGISER PARTNERS 4416 CHESAPEAKE STREET NW WASHINGTON DC 20016 GOVERNMENT RELATIONS 240000 PERKINS COIE LLP PO BOX 24643 SEATTLE WA 98124 POLICY/STRATEGY 165000 LYNN MARIE MARQUIS 412 S VEITCH STREET ARLINGTON VA 22204 PROJECT MANAGEMENT 120000 RED MAPLE CONSULTING LLC 6929 CONSERVATION DRIVE SPRINGFIELD VA 22153 POLICY/STRATEGY 110000 5 3958577 31173 3958577 PARTNER PROGRAMS 900003 1455500 1455500 DUES 900003 1316800 1316800 NATIONAL FORUM 900003 812600 812600 3584900 93419 93419 42352 21929 20423 20423 20423 227299 436345 -209046 -209046 -209046 MISCELLANEOUS 900099 23 23 23 7448296 3584900 0 -95181 X 37843 37843 870595 365650 178472 326473 2170587 1707027 357527 106033 136685 105468 23240 7977 365327 256840 64607 43880 193455 132976 33972 26507 8270 8270 69732 69732 316055 316055 23933 23933 817423 792700 21311 3412 255052 255052 35541 29493 1889 4159 110446 89778 6979 13689 221727 181316 11666 28745 52804 48113 682 4009 168482 166817 458 1207 155 155 63559 52118 3178 8263 15729 12898 786 2045 ADVOCACY AWARDS 107421 107421 SURVEYS 46200 46200 DUES AND SUBSCRIPTIONS 37507 31135 2317 4055 BOARD MEETINGS 22087 9966 10541 1580 16233 13328 802 2103 6162848 4860284 718427 584137 783889 918139 1756079 2001490 1725012 2987734 102 310 8357 19227 778427 483887 289160 294540 6580363 5389936 765519 1588230 11908481 13199606 352864 522117 1205474 1334786 1275793 2025394 2834131 3882297 X 1169067 1323449 7905283 7993860 9074350 9317309 11908481 13199606 1285448 -1042489 0 X X 0 1 X 1 0 X 1262696 1311426 2393648 7916222 3958577 16842569 2679720 2699700 2133500 2327412 3584900 13425232 3942416 4011126 4527148 10243634 7543477 30267801 369719 126197 98964 5484430 114790 6194100 162848 536988 260680 136154 1279934 2376604 532567 663185 359644 5620584 1394724 8570704 21697097 35401 64203 66202 73024 135771 374601 35401 64203 66202 73024 135771 374601 934 14684 631 23 16272 3978751 4075329 4608034 10317289 7679271 30658674 0.70770 0.69940 0.01220 0.00940 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2018 AMOUNT: $ 934. 2020 AMOUNT: $ 14,684. 2021 AMOUNT: $ 631. 2022 AMOUNT: $ 23. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9590 318796 328386 5856391 6184777 459239 114810 0 0 341496 333840 376049 459239 1510624 2265936 120691 76511 241801 328386 767389 85374 83460 94012 114810 377656 566484 9160 10570 8369 9590 37689 5393479 200000 -988940 200000 4404539 100000 5100000 193479 5393479 100000 100000 100000 100000 1.00000 0 0 524438 317953 206485 110951 66096 44855 143038 99838 43200 294540 DEPOSITS 38426 DEFERRED COMPENSATION INVESTMENTS 613783 RIGHT-OF-USE ASSETS - OPERATING LEASES 936021 1588230 DEFERRED COMPENSATION 613783 OPERATING LEASE LIABILITY 1396672 FINANCE LEASE LIABILITY 14939 2025394 X 6475613 -1042489 71810 21929 -948750 7424363 23933 23933 7448296 6232654 71810 21929 93739 6138915 23933 23933 6162848 PART V, LINE 4: THE BOARD OF DIRECTORS HAS DESIGNATED AN AMOUNT OF $449,472 FOR A FUTURE USE TO BE DETERMINED AT A LATER TIME AND ONLY UPON APPROVAL OF THE BOARD. THE ORGANIZATION'S ENDOWMENT WAS ESTABLISHED IN FEBRUARY 2020 AND CONSISTS OF ONE FUND, ESTABLISHED TO SUPPORT THE GORDON AND LLURA GUND LEADERSHIP AWARD PRESENTED BY THE ORGANIZATION ANNUALLY AT ITS ADVOCACY AWARDS EVENT. IN 2021 JOHNSON & JOHNSON ESTABLISHED A PERMANENT ENDOWMENT TO PROVIDE SPONSORSHIP SUPPORT FOR THE PUBLIC HEALTH AWARDS AS PART OF THE ADVOCACY AWARDS EVENT. PART X, LINE 2: THE ORGANIZATION FOLLOWS THE AUTHORITATIVE GUIDANCE RELATING TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES INCLUDED IN ACCOUNTING STANDARDS CODIFICATION TOPIC 740-10, INCOME TAXES. THESE PROVISIONS PROVIDE CONSISTENT GUIDANCE FOR THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS AND PRESCRIBE A THRESHOLD OF "MORE LIKELY THAN NOT" FOR RECOGNITION AND DERECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. IT IS THE ORGANIZATION'S POLICY TO RECOGNIZE INTEREST AND/OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSES. THE ORGANIZATION PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEAR ENDED DECEMBER 31, 2022 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION ON THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. THE STATUTE OF LIMITATIONS GENERALLY REMAINS OPEN FOR THREE TAX YEARS WITH THE U.S. FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH THE ORGANIZATION FILES TAX RETURNS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENT EXPENSES 21,929. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENT EXPENSES 21,929. PART XII, LINE 4B - OTHER ADJUSTMENTS: RENT EXPENSES X X X X X X 0 0 0 0 0 0 0 1 0 MARY WOOLLEY PRESIDENT & CEO 441854 0 73514 0 0 0 42807 0 24512 0 582687 0 0 0 MICHAEL COBURN EXECUTIVE VICE PRESIDENT & COO 276814 0 12000 0 0 0 23241 0 11554 0 323609 0 0 0 ELEANOR DEHONEY VP - POLICY & ADVOCACY 244190 0 12000 0 0 0 20680 0 11875 0 288745 0 0 0 JENNIFER LURAY VP - COMMUNICATONS 217747 0 12000 0 0 0 19603 0 24669 0 274019 0 0 0 SHEILA H MURPHY VP - ADVOCACY PROGRAMS 198358 0 0 0 0 0 1333 0 3050 0 202741 0 0 0 PART I, LINE 7 THE COMPENSATION COMMITTEE ESTABLISHES PERFORMANCE METRICS FOR THE CEO AT THE START OF THE YEAR WITH LEVELS OF ACHIEVEMENT DETERMINED (MEETS, EXCEEDS AND STRETCH GOALS). FOLLOWING THE CLOSE OF THE YEAR , THE COMMITTEE REVIEWS RESULTS WITH PERFORMANCE METRICS TO DETERMINE OVERALL LEVEL OF PERFORMANCE. THE COMMITTEE ENGAGES A COMPENSATION CONSULTANT TO REVIEW THE MARKET COMPARISON FOR TOTAL COMPENSATION. THE BONUS FOR THE CEO IS CALCULATED TO PLUS UP TOTAL COMPENSATION TO THE LEVEL THE COMMITTEE DETERMINES SO THAT THE TOTAL OF BASE SALARY PLUS BONUS EQUALS THE AGREED UPON LEVEL OF COMPENSATION. X 1 27033 FMV X WINE 1 4140 FMV 0 0 1 PART I, LINE 32B: RESEARCH!AMERICA ACCEPTS DONATIONS OF STOCK WHICH IS THEN SOLD VIA THEIR INVESTMENT FIRM. FORM 990, PART VI, SECTION A, LINE 6 RESEARCH!AMERICA IS A MEMBERSHIP ORGANIZATION. MEMBERSHIP IS OPEN TO ANY ORGANIZATION, PROFESSIONAL SOCIETY, ASSOCIATION, CORPORATION, INSTITUTION, OTHER ENTITY OR INDIVIDUAL WHICH IS INTERESTED IN AND SUPPORTIVE OF THE MISSION OF RESEARCH!AMERICA - TO MAKE RESEARCH FOR HEALTH A HIGHER NATIONAL PRIORITY. MEMBERS ARE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A EACH INSTITUTION MEMBER HAS ONE VOTE ON MATTERS SUBJECT TO A VOTE BY THE MEMBERSHIP. MEMBERS ELECT THE BOARD OF DIRECTORS AT THE ANNUAL MEETING. FORM 990, PART VI, SECTION A, LINE 7B MEMBERS MAY BE ASKED TO VOTE ON MATTERS OUTLINED IN THE BYLAWS (ELECTION OF DIRECTORS AND DISSOLUTION OR AMENDMENTS TO THE BYLAWS). FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PRESENTED TO THE AUDIT COMMITTEE IN CONJUNCTION WITH THE PRESENTATION OF THE AUDIT REPORT FOR THE YEAR ENDED. ONCE APPROVED BY THE COMMITTEE, THE FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS WHO ARE GIVEN A 48 HOUR PERIOD TO RESPOND WITH ANY ISSUES OR EDITS PRIOR TO FINALIZATION. FORM 990, PART VI, SECTION B, LINE 12C THE AUDIT COMMITTEE IS CHARGED WITH OVERSIGHT OF ADHERENCE TO THE CONFLICT OF INTEREST POLICY. ANNUALLY, EACH MEMBER OF THE BOARD OF DIRECTORS AND EACH MEMBER OF STAFF IS REQUIRED TO REVIEW THE POLICY AND SUBMIT A SIGNED DISCLOSURE STATEMENT. THE AUDIT COMMITTEE REVIEWS AND REPORTS TO THE BOARD OF DIRECTORS ANY POTENTIAL CONFLICT OF INTEREST. ANY DIRECTOR WITH A DISCLOSED CONFLICT SHALL RECUSE THEMSELVES FROM DELIBERATIONS ON ACTIONS THAT MAY BE CONSTRUED AS A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE IS CHARGED WITH OVERSIGHT OF EXECUTIVE COMPENSATION. THE COMPENSATION COMMITTEE, IN CONSULTATION WITH THE BOARD CHAIR, ESTABLISHES PERFORMANCE METRICS FOR THE CEO. FOLLOWING THE CLOSE OF THE YEAR, THE COMPENSATION COMMITTEE REVIEWS RESULTS TO DETERMINE THE OVERALL LEVEL OF PERFORMANCE. A THIRD PARTY COMPENSATION CONSULTANT IS ENGAGED TO REVIEW MARKET COMPENSATION FOR THE CEO AND KEY MANAGEMENT EMPLOYEES. THE COMPENSATION COMMITTEE PROPOSES CHANGES IN COMPENSATION FOR THE CEO BASED ON PERFORMANCE OUTCOMES TO THE BOARD CHAIR FOR APPROVAL BY THE EXECUTIVE COMMITTEE. ANY INCREASES IN COMPENSATION FOR KEY MANAGEMENT STAFF ARE PROPOSED BY THE CEO AND APPROVED BY THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 CODE OF ETHICS, CONFLICT OF INTEREST AND WHISTLEBLOWER POLICY AND FINANCIAL INFORMATION IS AVAILABLE ON THE ORGANIZATION'S WEB SITE, THESE AND OTHER GOVERNING DOCUMENTS ARE ALSO AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 792,700. MANAGEMENT AND GENERAL EXPENSES 21,311. FUNDRAISING EXPENSES 3,412. TOTAL EXPENSES 817,423. FORM 990, PART XII, LINE 2C THE PROCESS REMAINS UNCHANGED FROM THE PRIOR YEAR.